miR-214 was found to target fibroblast growth factor 9 (FGF9) in gastric cancer cells, and an experiment showed that it prevented cell fibrosis, increased the expression of E-cadherin, and decreased the expression of vimentin and N-cadherin to negatively regulate EMT [108]. This evidence concerns the gene CDH1 and gastric cancer.